Analytical Data
-
基因名
P93S,X94V
- Application
-
种属
Human immunodeficiency virus 1
-
表达系统
E. coli
-
标签
N- His
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
A0A0H4LST7
-
表达区间
1-117aa(P93S,X94V)
-
分子量
17.1 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
The study of the recombinant proteins P93S and X94V is rooted in the quest to understand the molecular mechanisms underpinning various biological processes and their implications in health and disease. P93S and X94V are specific variants derived from proteins of interest that are hypothesized to play crucial roles in particular cellular pathways or interactions. Research on these recombinant proteins often focuses on their structure, function, and the effects of the mutations on protein behavior. Variants like P93S and X94V may influence processes such as enzyme activity, signal transduction, or even protein stability, making them targets for detailed biochemical and biophysical studies. By expressing these proteins recombinantly, researchers can explore their properties in controlled environments, allowing for the assessment of their roles in pathological conditions, such as cancer or neurodegenerative diseases. The insights gained from these studies not only advance fundamental biological knowledge but may also pave the way for the development of novel therapeutic strategies targeting the specific features associated with these variants. As such, P93S and X94V serve as important tools in the ongoing exploration of protein functions and their related pathways in various biological contexts.
